The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vaxcyte, Inc(NASDAQ:PCVX) 
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops novel vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging ...
Website: http://www.vaxcyte.com
Founded: 2013
CEO: Grant E. Pickering
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Vaxcyte Days Payable Outstanding ttm (DPO)
Vaxcyte Days Inventory Outstanding ttm (DIO)
Vaxcyte Op Cashflow Per Share ttm
Vaxcyte Free Cashflow Per Share ttm
Vaxcyte Cash Per Share ttm
Vaxcyte (GAAP) P/E ratio ttm
Vaxcyte P/B ratio ttm
No extra charts and metrics for this ticker.